Plant Health Care seed test trials produce positive results

Biological products provider Plant Health Care has unveiled striking results relating to its Harpin seed trials.

Biological products provider Plant Health Care has unveiled striking results relating to its Harpin seed trials.

In a trading update providing details of its Harpin field trials, the group stated that the Harpin seed treatment had delivered substantial yield increases when combined with industry standard seed treatments in corn, soybeans and wheat.

Soybean treated with Harpin in addition to other products produced an additional two bushels per acre, the group reported. It stated that this was equivalent to an uplift in yield of approximately 3.5%, worth $25 per acre at current market prices. The group stated that this indicated an eight:one return on US farmers' investment in Harpin.

In corn, the use of Harpin increased yields over base insecticide and fungicide treatments by 18.6 bushels per acre, offering potential incremental revenue of $111 per acre.

In wheat, the use of Harpin added 2.8 bushels per acre in average yield beyond that achieved from a treatment consisting of only insecticide and fungicide. This would equate to additional revenue of $23 per acre.

The field trials were conducted as part of Direct Enterprise Inc.'s annual comprehensive seed treatment study and involved evaluation by independent contract researchers across 14 states, Plant Health Care stated, using the Random Complete Block design, with three replications per treatment at each location.

John Brady, Chief Executive Officer of Plant Health Care, commented: "These results clearly demonstrate that Harpin delivers an incremental yield beyond that which can be achieved using other market-leading treatments. We are very pleased with the corn and wheat data that came through the expanded 2012 testing program, while acknowledging that the corn results are extremely favorable as a consequence of the severe drought conditions experienced across much of the Midwest.

"While we're aware of the favourable effects that harpin can deliver in the presence of drought, we realize that similar conditions aren't likely to occur every year, and that the yield gains in corn will, under normal growing conditions, likely drop back into the three to five percent range that's consistent with what was seen in soybeans and wheat.

MF

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Why investors should be “cautiously bullish” for 2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

Here’s why you really should own at least some bitcoin
Bitcoin

Here’s why you really should own at least some bitcoin

While bitcoin is having a quiet year – at least in relative terms – its potential to become the default cash system for the internet is undiminished, …
16 Sep 2020
Will a second wave of Covid lead to another stockmarket crash?
Stockmarkets

Will a second wave of Covid lead to another stockmarket crash?

Can we expect to see another lockdown like in March, and what will that mean for your money? John Stepek explains.
18 Sep 2020
James Ferguson: How bad data is driving fear of a second wave of Covid-19
UK Economy

James Ferguson: How bad data is driving fear of a second wave of Covid-19

Merryn and John talk to MoneyWeek regular James Ferguson about the rise in infections in coronavirus and what the data is really telling us.
17 Sep 2020